Oxular in Drug Discovery World
An-excellent-summary-about-the-potential-of-our-lead-program-oxu-001-from-drug-discovery-world. “An innovative sustained release formulation of dexamethasone currently under investigation for use in DME offers the potential for effective anti-inflammatory treatment with significantly fewer injections and a high likelihood of fewer side effects, as its levels in the vitreous and anterior segment are minimal. This will limit the frequency of IOP elevation and cataract …